WAKIX Demonstrated Efficacy and Safety in Clinical Studies in Adult and Pediatric Patients With Narcolepsy Type 1 or Narcolepsy Type 2

WAKIX was evaluated in adult and pediatric patients with narcolepsy type 1 and narcolepsy type 2

Learn more about the clinical study results for WAKIX in both excessive daytime sleepiness (EDS) and cataplexy in patients 6 years and older with narcolepsy, and view the WAKIX safety profile from clinical studies.